Allay Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.allaytx.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Study Assessing Pain Relief After Replacement of the Knee
Phase 2
Recruiting
- Conditions
- Total Knee Arthroplasty (Postoperative Pain)
- Interventions
- First Posted Date
- 2025-01-29
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Allay Therapeutics, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06799845
- Locations
- 🇺🇸
Clinical Pharmacology of Miami, LLC, Miami, Florida, United States
🇺🇸Woodland International Research Group, LLC, Little Rock, Arkansas, United States
🇺🇸Phoenix Clinical Research, Tamarac, Florida, United States
Study Assessing Pain Relief After Replacement of the Knee
Phase 2
Terminated
- Conditions
- Acute Postoperative Pain
- Interventions
- First Posted Date
- 2022-03-02
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Allay Therapeutics, Inc.
- Target Recruit Count
- 112
- Registration Number
- NCT05260008
- Locations
- 🇦🇺
Prince of Wales Private Hospital, Sydney, New South Wales, Australia
🇦🇺John Flynn Private Hospital, Tugun, Queensland, Australia
🇦🇺Royal Adelaide Hospital / PARC Clinical Research, Adelaide, South Australia, Australia
News
No news found